Last reviewed · How we verify
NCT04309214
Market Research - Acceptability Study for New MCT Fat Products
NA trial testing MCT fats in Ketosis in 12 participants. Completed in 21 January 2019.
21 January 2019
Quick facts
| Lead sponsor | Dr. Schär AG / SPA |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 12 |
| Start date | 26 November 2018 |
| Primary completion | 21 January 2019 |
| Estimated completion | 21 January 2019 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- MCT fats
Conditions studied
- Ketosis — all drugs for Ketosis →
- Epilepsy — all drugs for Epilepsy →
- Fatty Acid Oxidation Disorder — all drugs for Fatty Acid Oxidation Disorder →
- Malabsorption — all drugs for Malabsorption →
Sponsor
Dr. Schär AG / SPA
Who can join
Adults 3 to 20, any sex, with Ketosis or Epilepsy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a market research, observational study to evaluate the tolerability and acceptability of MCT supplements for young children, young people and adults with intractable epilepsy, GLUT-1 or PDHD from 3 years to adulthood.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04309214
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of MCT fats
Trials testing the same drug.
- NCT04309149 — Market Research - Acceptability Study for a Range of MCT Products · NA · completed
Other recruiting trials for Ketosis
Currently open trials in the same condition.
- NCT06815237 — Effects of Ketone Supplement and Alcohol on Brain Metabolism · Phase 2, PHASE3 · recruiting
- NCT06338969 — The Impact of Different Carbohydrate Restriction After a Gastric Bypass on the Ketosis and Ketoacidosis · NA · recruiting
- NCT05924295 — Variations in Ketone Metabolism · NA · recruiting
Other Dr. Schär AG / SPA trials
Trials by the same sponsor.
- NCT04519827 — A Hypoallergenicity Study on a New Rice-Based Hydrolysate Formula · NA · completed
- NCT04318509 — Market Research - Acceptability Study for a New PKU Protein Substitute · NA · completed
- NCT04309149 — Market Research - Acceptability Study for a Range of MCT Products · NA · completed
- NCT04309331 — Market Research - Acceptability Trial for a New PKU Amino Acid Based Protein Substitute · NA · completed
- NCT04400422 — Experience of Using Lipano in Children With Fatty Acid Oxidation Disorders · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04309214 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dr. Schär AG / SPA
- Last refreshed: 16 March 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04309214.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing